• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体疾病患者的麻醉管理:当前最佳证据综述。

Anesthetic Management of the Patient with Mitochondrial Disease: A Review of Current Best Evidence.

机构信息

is a practicing CRNA in the Washington, D.C. metro area. This Journal course was written during the author's doctoral candidacy at Virginia Commonwealth University, Richmond, Virginia. Email:

出版信息

AANA J. 2022 Apr;90(2):148-154.

PMID:35343897
Abstract

Anesthetic management of the patient with mitochondrial disease (MD) requires thoughtful preoperative planning and hypervigilant perioperative monitoring. MD affects 1 in 4,000 persons and is often an unfamiliar topic to the anesthesia provider. This review aims to inform the anesthetist on important considerations in perioperative management of MD. Patients with MD have impaired mitochondrial energy formation pathways affecting function of cardiac, central nervous, and musculoskeletal systems. All general anesthetics interfere with these mitochondrial bioenergetic pathways. MD patients exhibit hypersensitivity to volatile anesthetics. Propofol interferes with mitochondrial function via multiple pathways thus its use should be limited. MD is not at increased risk for malignant hyperthermia and should not be managed with prolonged propofol infusion. Succinylcholine is contraindicated due to hyperkalemia and myotonic risks. Nondepolarizing agents should be used with caution given unpredictable effects. No single anesthetic plan has been found to be safer than another in patients with MD. Intravenous and volatile anesthetics should be titrated incrementally while monitoring anesthetic depth clinically or via processed electroencephalogram (EEG). All MD patients should be optimized by minimizing fasting times, careful fluid selection to avoid lactate, and hypervigilant temperature management aimed at reducing the detrimental effects of catabolic stress during the perioperative period.

摘要

线粒体疾病 (MD) 患者的麻醉管理需要深思熟虑的术前规划和高度警惕的围手术期监测。MD 影响每 4000 人中的 1 人,并且通常是麻醉提供者不熟悉的主题。本综述旨在为麻醉师提供 MD 围手术期管理的重要注意事项。MD 患者的线粒体能量形成途径受损,影响心脏、中枢神经系统和肌肉骨骼系统的功能。所有全身麻醉药都会干扰这些线粒体生物能途径。MD 患者对挥发性麻醉剂表现出过敏反应。丙泊酚通过多种途径干扰线粒体功能,因此应限制其使用。MD 发生恶性高热的风险不增加,不应使用长时间的丙泊酚输注来进行管理。由于高钾血症和肌强直性风险,琥珀酰胆碱禁忌使用。应谨慎使用非去极化剂,因为其作用不可预测。在 MD 患者中,尚未发现某种麻醉方案比另一种更安全。应逐渐滴定静脉和挥发性麻醉剂,同时通过临床监测或经处理的脑电图 (EEG) 监测麻醉深度。所有 MD 患者都应通过最小化禁食时间、谨慎选择避免乳酸的液体以及高度警惕的体温管理来优化,以减少围手术期分解代谢应激的有害影响。

相似文献

1
Anesthetic Management of the Patient with Mitochondrial Disease: A Review of Current Best Evidence.线粒体疾病患者的麻醉管理:当前最佳证据综述。
AANA J. 2022 Apr;90(2):148-154.
2
Perioperative considerations in adult mitochondrial disease: A case series and a review of 111 cases.成人线粒体疾病的围手术期注意事项:病例系列及111例病例回顾
Mitochondrion. 2016 Jan;26:26-32. doi: 10.1016/j.mito.2015.11.004. Epub 2015 Nov 19.
3
Anesthetic drugs and onset of malignant hyperthermia.麻醉药物与恶性高热的发作。
Anesth Analg. 2014 Feb;118(2):388-396. doi: 10.1213/ANE.0000000000000062.
4
Anesthetic Management of Coronary Artery Bypass Grafting in a Patient with Charcot-Marie-Tooth Disease and Multivessel Coronary Artery Disease.Charcot-Marie-Tooth 病合并多支冠状动脉疾病患者行冠状动脉旁路移植术的麻醉管理。
Am J Case Rep. 2023 Dec 20;24:e940284. doi: 10.12659/AJCR.940284.
5
Anesthetic consideration for neuromuscular diseases.神经肌肉疾病的麻醉考量
Curr Opin Anaesthesiol. 2017 Jun;30(3):435-440. doi: 10.1097/ACO.0000000000000466.
6
Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series.线粒体脑肌病、乳酸酸中毒和卒中样发作综合征的麻醉考虑因素:病例系列。
Can J Anaesth. 2011 Aug;58(8):751-63. doi: 10.1007/s12630-011-9528-0. Epub 2011 Jun 9.
7
[Anesthetic management for patients with mitochondrial disease].[线粒体疾病患者的麻醉管理]
Masui. 2014 Jan;63(1):49-56.
8
Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.琥珀酰胆碱引发恶性高热的相对风险估计。
Anesth Analg. 2013 Jan;116(1):118-22. doi: 10.1213/ANE.0b013e31826f5e3b. Epub 2012 Dec 7.
9
Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review.绘制成人神经肌肉疾病患者麻醉管理当前证据图谱:范围综述。
Can J Anaesth. 2022 Jun;69(6):756-773. doi: 10.1007/s12630-022-02230-3. Epub 2022 Mar 23.
10
Malignant hyperthermia and muscular dystrophies.恶性高热与肌营养不良症。
Anesth Analg. 2009 Oct;109(4):1043-8. doi: 10.1213/ane.0b013e3181aa5cf6.

引用本文的文献

1
Management of anesthesia in a child with mitochondrial disease for dental rehabilitation.线粒体疾病患儿牙科康复的麻醉管理
J Anaesthesiol Clin Pharmacol. 2025 Jan-Mar;41(1):204-205. doi: 10.4103/joacp.joacp_542_23. Epub 2025 Jan 23.
2
Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome.遗传线粒体疾病 Leigh 综合征中的挥发性麻醉剂毒性。
Br J Anaesth. 2023 Nov;131(5):832-846. doi: 10.1016/j.bja.2023.08.009. Epub 2023 Sep 26.